Esperion Therapeutics Inc (ESPR)

Esperion Therapeutics Inc Azioni (ESPR) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	327.09% 137.74	32.25	33.97	25.79	24.33
Cost Of Revenue	53.47	-	-	-	-
Gross Profit	91.46	-	-	-	-
Operating Expenses	12.26% 65.47	74.62	61.50	62.84	72.93
Interest Income/Expense	6.86% 14.02	15.06	14.99	14.54	14.39
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	12.26% 65.47	74.62	61.50	62.84	72.93
Operating Income/Loss	270.58% 72.27	-42.37	-27.53	-37.06	-48.60
Income/Loss From Continuing Operations Before Tax	327.09% 137.74	32.25	33.97	-49.94	-61.72
Income Tax Expense/Benefit, Deferred	-4.412	-	-	-	-
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	208.30% 61.02	-56.34	-41.25	-49.94	-61.72
Net Income/Loss	208.30% 61.02	-56.34	-41.25	-49.94	-61.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,302% 169.26	3.133	111.87	109.24	78.44
Diluted Average Shares	5,953% 189.64	3.133	111.87	109.24	78.44
Basic Earnings Per Share	172.00% 0.36	-0.50	-0.37	-0.46	-0.79
Diluted Earnings Per Share	168.00% 0.34	-0.50	-0.37	-0.46	-0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-